Ideaya Biosciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +452.3% | +17.0% | +164.0% | +27.9% | +1.7% | +67.4% | +73.1% | -1.3% | |
| – | +567.8% | +12.1% | +183.9% | -13.0% | +47.6% | +43.8% | +29.5% | -3.3% | |
| – | +244.0% | +66.1% | +111.5% | +27.8% | -25.4% | +128.8% | -46.3% | +33.7% | |
| – | +583.8% | +10.0% | +186.6% | -13.0% | +47.8% | +43.9% | +28.8% | -5.5% | |
| – | – | – | – | -41.2% | -80.9% | -91.5% | -83.3% | +199,000.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | +37.6% | +88.3% | -2.3% | -49.7% | +36.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +338.0% | -91.3% | +693.5% | -20.2% | -51.8% | -26.7% | +130.1% | +33.0% | |
| – | +122.4% | +28.2% | +456.8% | +16.9% | -29.8% | -14.6% | +70.0% | +27.7% | |
| – | – | – | +34.5% | +10.3% | +10.1% | -6.6% | -82.9% | +13.8% | |
| – | +114.0% | -50.0% | +34.4% | +120.4% | +103.8% | +54.2% | +133.7% | +14.0% | |
| – | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | +97.5% | +52.1% | +15.9% | +77.7% | +70.5% | -3.4% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +42.1% | +22.2% | +42.6% | +17.6% | +38.8% | +42.0% | +8.3% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.